BMC Endocrine Disorders

tracked for impact factor
Search for
Advanced search
Submit a manuscript Register Sign up for article alerts Contact us

Articles

Volume 11 (2011) - May 2011

next >
up
< previous

Research article   Open Access

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

Astrid K Stunes, Irene Westbroek, Björn I Gustafsson, Reidar Fossmark, Jan H Waarsing, Erik F Eriksen, Christiane Petzold, Janne E Reseland, Unni Syversen BMC Endocrine Disorders 2011, 11:11 (26 May 2011)

Abstract | Full text | PDF | PubMed

Research article   Open Access

Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study

Huy A Tran, Tracey L Jones, Robert Gibson, Glenn EM Reeves BMC Endocrine Disorders 2011, 11:10 (24 May 2011)

Abstract | Full text | PDF | PubMed